Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The National Institute for Health Research (NIHR) Oxford Biomedical Research (BRC) is holding a series of free events including talks, tours and exhibitions, on the latest advances in research to improve healthcare.

The BRC brings together researchers and clinicians from Oxford University Hospitals NHS Trust and Oxford University to improve healthcare through translational research - taking laboratory research into a clinical setting.  

From 6- 21 March, the BRC ‘Open Weeks’ will showcase some of this world-leading research. This ties in with the Oxfordshire Science Festival and British Science Week.

Events are taking place at a host of venues including the Oxford Natural History Museum and Oxford’s hospitals. All events are free and open to all.

Highlights include a behind–the-scenes look at state-of-the-art scanning facilities.

There will be talks on the latest research into the heart, cancer, blood, genomic medicine and more, as well as interactive exhibitions explaining how technology is revolutionising healthcare in hospital and at home. Vasiliki Kiparoglou, Head of Operations, NIHR Oxford BRC, said:“Oxford  has long been at the forefront of medical research, whether it is the genetic and molecular basis of disease, the latest advances in neuroscience, or clinical studies in cancer, diabetes, heart disease, stroke and other conditions. This is a fantastic opportunity to learn about the benefits to patients of the latest developments in healthcare research.”

More information on the Oxford BRC Open Weeks

 

Similar stories

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Clinical Trials Coronavirus COVID-19 Research

Inhaled budesonide, a common corticosteroid, is the first widely available, inexpensive drug found to shorten recovery times in COVID-19 patients aged over 50 who are treated at home and in other community settings, reports the PRINCIPLE trial in 1,779 participants.

AIMday in Women's Health - registration for academics now open

Events Innovation

Are you an academic interested in finding out how your knowledge can be used to solve industry challenges? Would you like to widen your network? Meet potential collaborators / future employees? Gain insights into relevant funding schemes? If you answer YES to any of the above, now is the time to register for the AIMday in Women's Health.

Link between COVID-19 infection and subsequent mental health and neurological conditions found

Coronavirus COVID-19 General Research

One in three COVID-19 survivors received a neurological or psychiatric diagnosis within six months of infection with the SARS-CoV-2 virus, an observational study of more than 230,000 patient health records published in The Lancet Psychiatry journal estimates. The study looked at 14 neurological and mental health disorders.

New national study of long-term impacts of debilitating lung damage from COVID-19

Coronavirus COVID-19 General Research

A new national study will investigate the long-term effects of lung inflammation and scarring from COVID-19. The study, launched with £2 million of funding from UK Research and Innovation (UKRI), aims to develop treatment strategies and prevent disability.

Opportunities for final goodbyes must be prioritised in COVID-19 pandemic

Coronavirus COVID-19 General Research

Bereaved relatives described the ongoing pain of being absent at the end of a loved-one's life. Many had not seen their relative for weeks or months due to the pandemic. Opportunities must be prioritised for essential connections between families at end-of-life care.